Drug Makers Gear Up For Round Two In Lipitor Case

Law360, New York (November 3, 2005, 12:00 AM EST) -- Although attention has now turned to the ongoing Lipitor litigation in the United States, Ranbaxy and Pfizer will continue their U.K. battle over the blockbuster anti-cholesterol drug after Ranbaxy was cleared to appeal a ruling of infringement handed down last month.

“Ranbaxy is encouraged to have been granted the opportunity to make its case on the infringement decision on the other patent before the U.K. Court of Appeals,” said Malvinder Singh, Ranbaxy president.

On Oct. 12, a High Court judge ruled that Ranbaxy’s proposed Lipitor generic...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.